Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002535 · ClinicalTrials.gov registry record · Phase 2

Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

A Phase 2 study of Melanoma (Skin), sponsored by St. Luke's Medical Center.

Completed
Registry status
Phase 2
Development phase
1
Study location

NCT00002535 is a Phase 2 study of Melanoma (Skin) that has completed, run by St. Luke's Medical Center. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002535, a Phase 2 study of Melanoma (Skin), has completed, sponsored by St. Luke's Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
1
Study location

Study Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop tumor cells from growing. Combining biological therapies with indomethacin and cyclophosphamide may kill more tumor cells. PURPOSE: Phase II trial to compare the effectiveness of indomethacin and biological therapy with or without cyclophosphamide in treating patients who have advanced melanoma that has not responded to previous therapy.

Conditions Studied

Melanoma (Skin)

Interventions

  • DRUG cyclophosphamide
  • BIOLOGICAL aldesleukin
  • BIOLOGICAL therapeutic tumor infiltrating lymphocytes
  • BIOLOGICAL lymphokine-activated killer cells
  • DRUG indomethacin

Study Locations (1)

Wisconsin

  • St. Luke's Medical Center - Milwaukee

Trial Details

FieldValue
Start Date 1993-07
Est. Completion 2004-07
Phase Phase 2

Sponsor

St. Luke's Medical Center

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002535

The ClinicalTrials.gov registry entry for NCT00002535 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is St. Luke's Medical Center, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma (Skin) appearing as the primary indexed condition, and to 5 interventions - of which cyclophosphamide is the first listed.

NCT00002535 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00002535 about?

NCT00002535 is a clinical study titled "Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma". RATIONALE: Biological therapies use different ways to stimulate the immune system and stop tumor cells from growing. Combining biological therapies with indomethacin and cyclophosphamide may kill more tumor cells. PURPOSE: Phase II trial to compare the effectiveness of indomethacin and biological t...

What is the current status of trial NCT00002535?

This trial is currently completed. It is a Phase 2 study. The study started on 1993-07. Estimated completion is 2004-07.

What conditions does trial NCT00002535 study?

This clinical trial studies the following conditions: Melanoma (Skin).

What interventions are being tested in trial NCT00002535?

The interventions under investigation include: cyclophosphamide (DRUG), aldesleukin (BIOLOGICAL), therapeutic tumor infiltrating lymphocytes (BIOLOGICAL), lymphokine-activated killer cells (BIOLOGICAL), indomethacin (DRUG).

Who is sponsoring clinical trial NCT00002535?

This trial is sponsored by St. Luke's Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002535 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Melanoma (Skin)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Melanoma (Skin)

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.